BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24847950)

  • 1. Gr-1 Ab administered after bone marrow transplantation plus thymus transplantation suppresses tumor growth by depleting granulocytic myeloid-derived suppressor cells.
    Shi M; Li M; Cui Y; Adachi Y; Ikehara S
    PLoS One; 2014; 9(5):e97908. PubMed ID: 24847950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
    Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
    Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects.
    Miyake T; Hosaka N; Cui W; Nishida T; Takaki T; Inaba M; Kamiyama Y; Ikehara S
    Immunology; 2009 Apr; 126(4):552-64. PubMed ID: 18778285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.
    Wang D; Yu Y; Haarberg K; Fu J; Kaosaard K; Nagaraj S; Anasetti C; Gabrilovich D; Yu XZ
    Biol Blood Marrow Transplant; 2013 May; 19(5):692-702. PubMed ID: 23376089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of allogeneic hematopoietic stem cell transplantation plus thymus transplantation on malignant tumors: comparison between fetal, newborn, and adult mice.
    Zhang Y; Hosaka N; Cui Y; Shi M; Ikehara S
    Stem Cells Dev; 2011 Apr; 20(4):599-607. PubMed ID: 20672991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
    van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
    J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment.
    Cui W; Hosaka N; Miyake T; Wang X; Guo K; Cui Y; Li Q; Song C; Feng W; Li Q; Takaki T; Nishida T; Inaba M; Ikehara S
    Transplantation; 2008 Apr; 85(8):1151-8. PubMed ID: 18431236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intrabone marrow-bone marrow transplantation plus adult thymus transplantation on survival of mice bearing leukemia.
    Zhang Y; Hosaka N; Cui Y; Shi M; Li M; Li Q; Ikehara S
    Stem Cells Dev; 2012 Jun; 21(9):1441-8. PubMed ID: 21861761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantation.
    Li M; Abraham NG; Vanella L; Zhang Y; Inaba M; Hosaka N; Hoshino S; Shi M; Ambrosini YM; Gershwin ME; Ikehara S
    J Autoimmun; 2010 Dec; 35(4):414-23. PubMed ID: 20884174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
    Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
    Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
    Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
    Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
    Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of granulocytic myeloid-derived suppressor cells (G-MDSCs) could reduce colitis in experimental murine models.
    Su H; Cong X; Liu YL
    J Dig Dis; 2013 May; 14(5):251-8. PubMed ID: 23279711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice.
    Qu P; Yan C; Blum JS; Kapur R; Du H
    J Immunol; 2011 Oct; 187(7):3854-66. PubMed ID: 21900179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
    Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus-independent expansion of T lymphocytes in children after allogeneic bone marrow transplantation.
    Honda K; Takada H; Nagatoshi Y; Akazawa K; Ohga S; Ishii E; Okamura J; Hara T
    Bone Marrow Transplant; 2000 Mar; 25(6):647-52. PubMed ID: 10734299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.
    Mukaide H; Adachi Y; Koike-Kiriyama N; Suzuki Y; Minamino K; Iwasaki M; Tsuda M; Nakano K; Koike Y; Shigematsu A; Kamiyama Y; Ikehara S
    Int J Oncol; 2007 Jun; 30(6):1309-15. PubMed ID: 17487350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
    Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.